Cargando…
Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
BACKGROUND & OBJECTIVES: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) continues to be a devastating pandemic. This study was aimed at performance assessment of SARS-CoV-2 IgM and IgG ELISAs, and investigation of their utility for pati...
Autores principales: | Kulkarni, Ruta, Shrivastava, Shubham, Patil, Harshad P., Kore, Pravin, Rane, Prajakta, Palkar, Sonali, Lalwani, Sanjay, Mishra, Akhilesh Chandra, Arankalle, Vidya A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555602/ https://www.ncbi.nlm.nih.gov/pubmed/34145085 http://dx.doi.org/10.4103/ijmr.IJMR_3806_20 |
Ejemplares similares
-
Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA
por: Kulkarni, Ruta, et al.
Publicado: (2021) -
Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India
por: Shrivastava, Shubham, et al.
Publicado: (2021) -
Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad
por: Shrivastava, Shubham, et al.
Publicado: (2021) -
Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity
por: Kulkarni‐Munje, Archana, et al.
Publicado: (2021) -
Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)